Job Description

Interested in helping to develop cutting edge AI products to empower cancer diagnostics and save lives? If so, we’d love to talk to you!

BioAI is an early-stage company that has developed the unique AI-powered PredictX platform that analyzes digital tumor tissue slides to predict genetic biomarkers. It uses the footprint that specific genetic mutations leave in the tissue architecture and morphology.

Unlike standard molecular testing this is

• Fast, hours instead of weeks: very helpful for patients with progressive cancer
• Much cheaper
• and can analyze an entire panel of different biomarker profiles from a single tissue slide: very useful in many cases when only a small volume of tumor tissue is available from a patient.

Our current customers are pharmaceutical companies that need effective tests to identify cancer patients eligible for their precision therapies.

Come join BioAI and make a difference! We’re a fast-growing team with industry experts and innovators in artificial intelligence, translational science ...